Insmed Incorporated (Nasdaq: INSM) today announced that, following
discussions with European regulatory authorities, it intends to file by
the end of 2014 a Marketing Authorization Application (MAA) with the
European Medicines Agency (EMA) for ARIKAYCE™, or liposomal amikacin for
inhalation, for the treatment of nontuberculous mycobacteria (NTM) lung
infections in treatment refractory patients as well as for Pseudomonas
aeruginosa lung infections in cystic fibrosis (CF) patients.
NEW YORK (MarketWatch) -- Cardinal Health Inc. (CAH) said it earned $234 million, or 68 cents a share, in its fiscal fourth quarter, after a loss of $586 million, or $1.72 a share, in the same period a year ago when it booked a goodwill impairment charge relating to its nuclear division.
Second Quarter Highlights: Revenue of $101.3 million, up 2.3% year-over-year Loss from continuing operations of $(2.6) million; as adjusted income from continuing operations of $6.4 million Loss per share from continuing operations of $(0.07); as adjusted earnings per share from continuing operations of $0.17 Debt leverage at 3.01 times as adjusted LTM EBITDA
WARSAW, Ind., Aug.
Names new CFO, Simona Green, and North America VP Sales of Public Sector Solutions, Jason Gilbert HERZLIYA, Israel and NEW YORK , August 4, 2014 /PRNewswire/ --
SuperCom (NASDAQ: SPCB) , a leading provider of Electronic Intelligence Solutions for National ID, Public Safety and HealthCare, announced today that it has named Ms.
Accenture (NYSE:ACN) is offering a new version of its Air
Cargo Operations software, part of the Accenture
Freight and Logistics Software portfolio, intended to help air cargo
carriers run more efficient and flexible cargo operations from
acceptance of cargo at origin through delivery of cargo at destination.
Agenus Inc. (Nasdaq:AGEN), an immuno-oncology company developing a
portfolio of checkpoint modulators (CPMs), heat shock protein vaccines
and adjuvants, today announced that Robert Stein, MD, PhD, the company’s
Chief Scientific Officer, will speak at Cambridge Healthtech Institute‘s
Second Annual Conference on Immunomodulatory Therapeutic Antibodies For
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.